Literature DB >> 15990720

Adrenal cortex -- the next biological clock?

Marek Pawlikowski1.   

Abstract

It is well known that plasma levels of dehydroepiandrosterone (DHEA), a steroid hormone secreted by zona reticularis (ZR) of the adrenal cortex, reach the maximal values in the third decade of life and then gradually decline with age. Moreover, the DHEA deficiency is probably responsible for several functional disturbances connected with aging. It was also found that ZR reaches its definitive volume at puberty and undergoes selective atrophy during the aging. Thus, the decline of DHEA may be a simple consequence of ZR atrophy in aged subjects. A hypothesis presented here attempts to explain the mechanism of the age-related ZR atrophy and is based on the adrenal cortex cell kinetics. In the adrenal cortex the cell proliferation indices are lower when we pass from zona glomerulosa (ZG) to the inner zones and are the lowest in ZR. In contrast, the apoptotic index is the highest in ZR. It is suggested that adrenocortical cells renew from the progenitor cells located in ZG /zona fasculata boundary and /or in subcapsular layer. These cells migrate centripetally undergoing the subsequent steps of differention and consecutive divisions - and - if not die en route - reach the most central localization in ZR. In consequence, ZR includes the "oldest" adrenocortical cells which probably in majority reached the "Hayflick's number" and cannot divide. This results in the preponderance of apoptosis over proliferation leading to progressive ZR atrophy followed by a decline of secretion of ZR-derived steroid hormones.

Entities:  

Mesh:

Year:  2005        PMID: 15990720

Source DB:  PubMed          Journal:  Neuro Endocrinol Lett        ISSN: 0172-780X            Impact factor:   0.765


  4 in total

Review 1.  Development and function of the human fetal adrenal cortex: a key component in the feto-placental unit.

Authors:  Hitoshi Ishimoto; Robert B Jaffe
Journal:  Endocr Rev       Date:  2010-11-04       Impact factor: 19.871

Review 2.  Dehydroepiandrosterone and dehydroepiandrosterone sulphate in atopic allergy and chronic urticaria.

Authors:  Alicja Kasperska-Zajac; Zenon Brzoza; Barbara Rogala
Journal:  Inflammation       Date:  2008-02-21       Impact factor: 4.092

3.  Does omalizumab treatment affect serum dehydroepiandrosterone sulphate levels in chronic idiopathic urticaria?

Authors:  Atıl Avcı; Deniz Avcı; Ragip Ertas; Mustafa Atasoy; Cigdem Karakukcu; Efşan Yontar; Yilmaz Ulas; Kemal Ozyurt
Journal:  Postepy Dermatol Alergol       Date:  2019-02-22       Impact factor: 1.837

Review 4.  Cellular Senescence in Adrenocortical Biology and Its Disorders.

Authors:  Xin Gao; Faping Li; Bin Liu; Yuxiong Wang; Yishu Wang; Honglan Zhou
Journal:  Cells       Date:  2021-12-09       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.